![Premal Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Premal Patel worked as Head-Early Clinical Development at Pfizer Inc. from 2015 to 2017.
He then worked as SVP & Head-Early Clinical Drug Development at Juno Therapeutics, Inc. from 2017 to 2018.
From 2018 to 2020, he served as Chief Medical Officer at Lyell Immunopharma, Inc. In 2021, he worked as Chief Medical Officer at eFFECTOR Therapeutics, Inc. Patel holds a doctorate degree from the University of Washington and an undergraduate degree from Rutgers State University of New Jersey.
Former positions of Premal Patel
| Companies | Position | End |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2022 |
| LYELL IMMUNOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 01/04/2020 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/04/2018 |
| PFIZER INC. | Corporate Officer/Principal | 01/08/2017 |
Training of Premal Patel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
76
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
- Stock Market
- Insiders
- Premal Patel
